Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia.
CONCLUSIONS: The results of the present study showed that MetS can negatively affect the response to medical treatment of BPH. Therefore, it is necessary to consider MetS in selecting patients with BPH for drug therapy.
PMID: 25512816 [PubMed - in process]
Source: Korean Journal of Urology - Category: Urology & Nephrology Tags: Korean J Urol Source Type: research
More News: Benign Prostatic Hyperplasia | Metabolic Syndrome | Primary Care | Propecia | Study | Urology & Nephrology